Press Releases

Trinity Biotech Announces Management Changes

December 27, 2023

Trinity Biotech announces the promotion of John Gillard, our Chief Financial Officer, to President and Chief Executive Officer, effective immediately.

Des Fitzgerald, who has served as Director of Corporate Development of Trinity Biotech since October 2022, has been promoted to Interim Chief Financial Officer, succeeding Mr. Gillard in that role

www.globenewswire.com/news-release/2023/12/18/2798156/0/en/Trinity-Biotech-Announces-Management-Changes.html

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Cookie	Type	Duration	Description
__stid	0	1 year	The cookie is set by ShareThis. The cookie is used for site analytics to determine the pages visited, the amount of time spent, etc.
__stidv	0	1 year	The cookie is set by ShareThis. The cookie is used for site analytics to determine the pages visited, the amount of time spent, etc.
_ga	0	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gat	0	1 minute	This cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
_gid	0	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_hrmts_locationString	1		Unclassified 3rd party cookie used by the HR Manager service
cookielawinfo-checkbox-necessary	0	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-non-necessary	0	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Non Necessary".
fpestid	0	1 year	Fpestid is a ShareThis cookie ID set in the domain of the website operator.
locale	session	1 month	Used by the site to show content to users based on their selected location.
test_cookie	0	11 months
viewed_cookie_policy	0	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Investor Relations

Press Releases

Trinity Biotech to Present at Emerging Growth Conference

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Trinity Biotech Announces Q3 2023 Financial Results Business Update

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

Trinity Biotech Announces Management Changes

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Trinity Biotech Announces Q2 2023 Financial Results

Trinity Biotech plc to Announce Q2 Fiscal Year 2023 Financial Results

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System

Trinity Biotech Announces Q1 2023 Financial Results

Trinity Biotech plc to Announce Q1 2023 Financial Results

Trinity Biotech Announces the Closing of its $30 Million Sale of its Life Sciences Supply Business to Biosynth

Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm

Trinity Biotech plc to Announce Q4 and Fiscal Year 2022 Financial Results

Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions

Investor Relations

Press Releases

Choose Location